Orthocell Limited (OCC) - Research

$0.445 0.02 (4.71%)

OCC General Information +

ASX Code OCC
Website http://www.orthocell.com.au
GICS Sub-Industry Biotechnology
Market Cap ($M) 68
Current Price $0.445
Day High $0.460
Day Low $0.425
Last Close $0.425
Price Movement $0.02 ( 4.71% )
Prices as at 16:40, 14 Jun 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

OCC Company Overview

Business Description

Orthocell Limited (OCC) is a regenerative medicine company focused on regenerating mobility for patients by developing products for the repair of a variety of soft tissue injuries. OrthocellÂ's portfolio of products include TGA-licensed cell therapies Autologous Tenocyte Implantation (Ortho-ATI) , Autologous Chondrocyte Implantation ( Ortho- ACI) , which aim to regenerate damaged tendon and cartilage tissue and CelGro.

OCC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -5.76 -5.50 0.00% 0.00 0.00 0.00% 0.0%
2017 A -4.18 -4.30 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.78 -4.30 0.00% 0.00 0.00 0.00% 0.0%

OCC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
CSL (CSL) $96,355M 0.3775 0.1479 0.1250 40.5106 35.2906 31.3707 1.45% 1.29% 1.48%
Clinuvel Pharmaceuticals (CUV) $1,654M 0.8671 0.0000 0.0000 126.5543 0.0000 0.0000 0.06% 0.00% 0.00%
Mesoblast (MSB) $726M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Orthocell (OCC) $65M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

OCC Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 20.70 0.00
Market 0.65 14.90 1.16 0.99
Sector 0.99 29.80 3.28 2.07

OCC Directors

Name Position Start Date
Dr Stewart James Washer Executive Chairman, Executive Director 7 Apr 2014
Mr Paul Frederick Anderson Managing Director 21 Mar 2006
Mr Matthew (Matt) Callahan Non-Executive Director 30 May 2006
Professor Lars Lidgren Non-Executive Director 17 Dec 2007
Mr Qi Xiao Zhou Non-Executive Director 2 Nov 2012

OCC Management

Name Position
Simon Lee Robertson Company Secretary

OCC Substantial Shareholders

Holding Name
9,530,382 (8.65%) SRV Custodians Pty Ltd
7,104,238 (6.45%) Ming Hao Zheng and Ying fan
6,403,335 (5.81%) Paul Anderson and Nicole Telford
5,996,241 (5.44%) Qi Xiao Zhou

OCC Calendar of Events

Date Event
26 February 2020 Report (Interim)
16 October 2019 Report (Annual)
30 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.